Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
Abstract Aims/Introduction Advanced glycation end‐products (AGEs), which are a major cause of diabetic vascular complications, accumulate in various tissues under chronic hyperglycemic conditions, as well as with aging in patients with diabetes. The loss of muscle mass and strength, so‐called sarcop...
Main Authors: | Hiroyasu Mori, Akio Kuroda, Masashi Ishizu, Mami Ohishi, Yuichi Takashi, Yinhua Otsuka, Satoshi Taniguchi, Motoyuki Tamaki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken‐ichi Aihara, Makoto Funaki, Yuko Akehi, Munehide Matsuhisa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.13014 |
Similar Items
-
High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study
by: Hiroyasu Mori, et al.
Published: (2021-06-01) -
Dynapenia: Term, causes and consequences
by: Međedović Bojan
Published: (2018-01-01) -
Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
by: Hiroki Nishikawa, et al.
Published: (2021-07-01) -
Physical function‐derived cut‐points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging
by: Anne‐Julie Tessier, et al.
Published: (2019-10-01) -
Sarcopenia, dynapenia and the impact of advancing age on human skeletal muscle size and strength; a quantitative review.
by: William Kyle Mitchell, et al.
Published: (2012-07-01)